Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation.

Visakorpi T, Kallioniemi OP, Heikkinen A, Koivula T, Isola J.

J Natl Cancer Inst. 1992 Jun 3;84(11):883-7.

PMID:
1350643
[PubMed - indexed for MEDLINE]
3.

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.

Isola J, Visakorpi T, Holli K, Kallioniemi OP.

J Natl Cancer Inst. 1992 Jul 15;84(14):1109-14.

PMID:
1352359
[PubMed - indexed for MEDLINE]
4.

p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting.

Borre M, Stausbol-Gron B, Overgaard J.

J Urol. 2000 Sep;164(3 Pt 1):716-21.

PMID:
10953132
[PubMed - indexed for MEDLINE]
5.

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.

Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC, Conti CJ.

J Natl Cancer Inst. 1993 Oct 20;85(20):1657-69.

PMID:
7692074
[PubMed - indexed for MEDLINE]
6.

Polymorphous low-grade adenocarcinoma: flow cytometric, p53, and PCNA analysis.

Kelsch RD, Bhuiya T, Fuchs A, Gentile P, Kahn MA, Fantasia JE.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Oct;84(4):391-9.

PMID:
9347503
[PubMed - indexed for MEDLINE]
7.

Proliferating cell nuclear antigen and p53 expression as prognostic factors in T1-2M0 prostatic adenocarcinoma.

Vesalainen SL, Lipponen PK, Talja MT, Alhava EM, Syrjänen KJ.

Int J Cancer. 1994 Jul 15;58(2):303-8.

PMID:
7913085
[PubMed - indexed for MEDLINE]
8.

p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.

Esrig D, Spruck CH 3rd, Nichols PW, Chaiwun B, Steven K, Groshen S, Chen SC, Skinner DG, Jones PA, Cote RJ.

Am J Pathol. 1993 Nov;143(5):1389-97.

PMID:
7901994
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.

Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH, et al.

J Natl Cancer Inst. 1992 Jun 3;84(11):845-55.

PMID:
1317462
[PubMed - indexed for MEDLINE]
10.

Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.

Isola J, Weitz S, Visakorpi T, Holli K, Shea R, Khabbaz N, Kallioniemi OP.

J Clin Oncol. 1993 Jan;11(1):36-43.

PMID:
8093367
[PubMed - indexed for MEDLINE]
11.

Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?

Cheville JC, Wu K, Sebo TJ, Cheng L, Riehle D, Lohse CM, Shane V.

Cancer. 2000 Feb 1;88(3):632-6.

PMID:
10649258
[PubMed - indexed for MEDLINE]
12.

Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.

Shiina H, Igawa M, Nagami H, Yagi H, Urakami S, Yoneda T, Shirakawa H, Ishibe T, Kawanishi M.

Cancer. 1996 Oct 15;78(8):1762-74.

PMID:
8859190
[PubMed - indexed for MEDLINE]
13.

DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma.

Pich A, Margaria E, Chiusa L, Ponti R, Geuna M.

Hum Pathol. 1996 Jul;27(7):676-82.

PMID:
8698311
[PubMed - indexed for MEDLINE]
14.

Biological characterisation of superficial bladder cancer by bivariate cytokeratin 7/DNA analysis, flow cytometric assessment of MIB- 1, and an immunohistochemical study.

Leonardi E, Dalla Palma P, Reich A, Caffo O, Luciani L.

Anal Cell Pathol. 2000;21(1):21-33.

PMID:
11254222
[PubMed - indexed for MEDLINE]
15.

Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.

Tanioka F, Hiroi M, Yamane T, Hara H.

Zentralbl Pathol. 1993 Aug;139(3):185-93.

PMID:
8105885
[PubMed - indexed for MEDLINE]
16.

Association of immunohistochemical p53 tumor suppressor gene protein overexpression with prognosis in highly proliferative human mammary adenocarcinomas.

Schimmelpenning H, Eriksson ET, Zetterberg A, Auer GU.

World J Surg. 1994 Nov-Dec;18(6):827-32; discussion 832-3.

PMID:
7846904
[PubMed - indexed for MEDLINE]
17.

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.

Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL.

J Natl Cancer Inst. 1993 Feb 3;85(3):200-6.

PMID:
8423624
[PubMed - indexed for MEDLINE]
18.
19.

p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.

Lopes A, Bezerra AL, Pinto CA, Serrano SV, de MellO CA, Villa LL.

J Urol. 2002 Jul;168(1):81-6.

PMID:
12050497
[PubMed - indexed for MEDLINE]
20.

Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.

Blom R, Guerrieri C, Stâl O, Malmström H, Simonsen E.

Gynecol Oncol. 1998 Jan;68(1):54-61.

PMID:
9454661
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk